This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...

has approved Kisqali® (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of people with hormone receptor-positive/human epidermal growth factor receptor 2-negative ...

Kajeet and Avery Telehealth announced a strategic partnership. The FDA has approved Apple’s sleep apnea detection feature.

FN Media Group News Commentary - Breast cancer is an illness in which the breast cells get uncontrollably large. The type of breast cancer depends on which cells in the breast become cancerous. Cancer ...

Breastfeeding through the first year of infants' lives can lower their risk of asthma by colonizing their bodies with a ...

Cannabis extract taken by the mouth could potentially provide additional relief for patients with chemotherapy-induced nausea ...

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...

(NASDAQ: LNTH), Sutro Biopharma, Inc. (NASDAQ: STRO), and Zymeworks Inc. (NASDAQ: ZYME). Backed by favorable results in its BRACELET-1 breast cancer study, Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ...

In the oncology world, there’s been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years.

New research shows about one in eight of all cancer cases are linked to common infections like HPV, Hepatitis B and C and H. pylori. NBC News medical contributor Dr. Natalie Azar joins TODAY to share ...

Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...

Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...